According to Veradigm, this is because the company did not file its annual report on form 10-K for the year ending Dec. 31, its quarterly report on form 10-Q for the quarter ending March 31, or a quarterly report on form 10-Q for the quarter ending on June 30, 2023.
The company was supposed to file these forms before the expiration of a 180-day exception period previously granted by Nasdaq, according to a Sept. 22 news release from Veradigm.
Veradigm said it could not file due to “internal control failures that primarily stem from accounting processes and a software tool,” according to the release.
Veradigm is looking to appeal Nasdaq’s decision.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
